Brief: Minerva Neurosciences Receives Second Written Notice From Nasdaq
June 2 (Reuters) - Minerva Neurosciences Inc NERV.O :
* MINERVA NEUROSCIENCES INC- ON MAY 31 RECEIVED A SECOND
WRITTEN
NOTICE FROM NASDAQ
* MINERVA NEUROSCIENCES- NASDAQ DETERMINED TO DELIST CO’S
SECURITIES FROM NASDAQ CAPITAL MARKET UNLESS CO REQUESTS HEARING
BEFORE NASDAQ HEARINGS PANEL
* MINERVA NEUROSCIENCES INC- INTENDS TO TIMELY REQUEST A
HEARING
BEFORE NASDAQ HEARING PANEL.
Source text for Eikon: ID:
Further company coverage: NERV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Minerva Neurosciences
See all newsU.S. RESEARCH ROUNDUP-Cisco, Fox Corp, Target
Brief: Minerva Neurosciences Provides Second Quarter 2026 Financial Results And Business Updates
Brief: Minerva Neurosciences - To Offer And Sell Up To $75 Million In Common Stock Through Leerink Partners
Brief: Minerva Announces Leadership Transition
Minerva Neurosciences Q4 net loss widens on non-cash financing charges